Benchmark Downgrades Bio-Techne to Hold

Bio-Techne Corporation

Bio-Techne Corporation

TECH

0.00

Benchmark analyst Robert Wasserman downgrades Bio-Techne (NASDAQ: TECH) from Buy to Hold.